Carroll Jill
- SEC CIK
- 0001598542
In the past year, 1 open-market purchase filing worth $5.00M and no sales.
Current role at each company
- AVLN Avalyn Pharma Inc.Directoras of May 1, 2026
- ACLX Arcellx, Inc.Directoras of Apr 28, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $5.00M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$5.00M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Carroll Jill as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AVLN Avalyn Pharma Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 (view filing) | May 1 | Same day | Carroll JillDirector | PPurchase | +277.8K | $18.00 | +$5.00M | +14.6%2.19M after |
ACLX Arcellx, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2024 (view filing) | Mar 21 | 4 days | Carroll JillDirector | SSale | −504.3K | $70.55 | −$35.6M | −25.4%1.48M after | |
| Dec 18, 2023 (view filing) | Dec 14 | 4 days | Carroll JillDirector | SSale | −504.3K | $49.13 | −$24.8M | −20.3%1.98M after | |
| Jun 2, 2023 (view filing) | May 31-Jun 1 | 2 days | Carroll JillDirector | SSale | −340.7K | $41.71 | −$14.2M | −12.0%2.49M after | 2 lots |
| May 15, 2023 (view filing) | May 11 | 4 days | Carroll JillDirector | SSale | −638.4K | $45.01 | −$28.7M | −18.4%2.83M after | 2 lots |
| Feb 9, 2022 (view filing) | Feb 8 | 1 day | Carroll JillDirector | PPurchase | +1.67M | $15.00 | +$25.0M | +454.7%2.03M after | 2 lots |